{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:10:28Z","timestamp":1790511028192,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["UL1TR000445"],"award-info":[{"award-number":["UL1TR000445"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.bbmt.2015.12.003","type":"journal-article","created":{"date-parts":[[2015,12,17]],"date-time":"2015-12-17T12:11:31Z","timestamp":1450354291000},"page":"528-535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenza Vaccine in Adult Hematopoietic Stem Cell Transplantation Patients"],"prefix":"10.1016","volume":"22","author":[{"given":"Natasha B.","family":"Halasa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bipin N.","family":"Savani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishan","family":"Asokan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adetola","family":"Kassim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhea","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsey","family":"Summers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carey","family":"Clifton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh Ann","family":"Vaughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Lucid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Fonnesbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madan","family":"Jagasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2015.12.003_bib1","unstructured":"HCT Trends and Survival Data. Available at: http:\/\/www.cibmtr.org\/ReferenceCenter\/SlidesReports\/SummarySlides\/pages\/index.aspx"},{"key":"10.1016\/j.bbmt.2015.12.003_bib2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2141.2008.07295.x","article-title":"The challenge of respiratory virus infections in hematopoietic cell transplant recipients","volume":"143","author":"Boeckh","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2015.12.003_bib3","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2015.12.003_bib4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbmt.2014.06.035","article-title":"Lost in transition: the essential need for long-term follow-up clinic for blood and marrow transplantation survivors","volume":"21","author":"Hashmi","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.12.003_bib5","unstructured":"Slides and reports. Available at: http:\/\/www.cibmtr.org\/ReferenceCenter\/SlidesReports\/Pages\/index.aspx"},{"key":"10.1016\/j.bbmt.2015.12.003_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2012.10.005","article-title":"Hematopoietic cell transplantation in 2020: summary of year 2 recommendations of the National Marrow Donor Program's System Capacity Initiative","volume":"19","author":"Denzen","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.12.003_bib7","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.bbmt.2013.07.020","article-title":"Prevalence of hematopoietic cell transplant survivors in the United States","volume":"19","author":"Majhail","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.12.003_bib8","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/sj.bmt.1705159","article-title":"The benefit of influenza vaccination after bone marrow transplantation","volume":"36","author":"Machado","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.12.003_bib9","first-page":"437","article-title":"Influenza A virus infections among hospitalized adult bone marrow transplant recipients","volume":"13","author":"Whimbey","year":"1994","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl","key":"10.1016\/j.bbmt.2015.12.003_bib10","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1053\/bbmt.2001.v7.pm11777102","article-title":"Respiratory virus infections in stem cell transplant patients: the European experience","volume":"7","author":"Ljungman","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.12.003_bib11","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/clinids\/22.5.778","article-title":"Community respiratory virus infections among hospitalized adult bone marrow transplant recipients","volume":"22","author":"Whimbey","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"3A","key":"10.1016\/j.bbmt.2015.12.003_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0002-9343(97)00007-7","article-title":"Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience","volume":"102","author":"Bowden","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.bbmt.2015.12.003_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/tid.12054","article-title":"European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN","volume":"15","author":"Engelhard","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2015.12.003_bib14","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1002\/cncr.11353","article-title":"Common community respiratory viruses in patients with cancer: more than just \u201ccommon colds\u201d","volume":"97","author":"Hicks","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2015.12.003_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0022-3476(89)80325-7","article-title":"Influenza in children with cancer","volume":"115","author":"Kempe","year":"1989","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.bbmt.2015.12.003_bib16","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1086\/425004","article-title":"Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy","volume":"39","author":"Nichols","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2015.12.003_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3201\/eid1701.091499","article-title":"Pandemic (H1N1) 2009 outbreak at camp for children with hematologic and oncologic conditions","volume":"17","author":"Morrison","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.bbmt.2015.12.003_bib18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12185-009-0464-5","article-title":"Influenza A\/pandemic 2009\/H1N1 in the setting of allogeneic hematopoietic cell transplantation: a potentially catastrophic problem in a vulnerable population","volume":"91","author":"Kharfan-Dabaja","year":"2010","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2015.12.003_bib19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1399-3062.2010.00569.x","article-title":"H1N1 infection in a cohort of hematopoietic stem cell transplant recipients: prompt antiviral therapy might be life saving","volume":"13","author":"Suyani","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2015.12.003_bib20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bbmt.2010.07.004","article-title":"The clinical impact of infection with swine flu (H1N109) strain of influenza virus in hematopoietic stem cell transplant recipients","volume":"17","author":"George","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.12.003_bib21","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.bbmt.2010.07.018","article-title":"Novel H1N1 influenza in hematopoietic stem cell transplant recipients: two center's experience","volume":"17","author":"Taplitz","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.12.003_bib22","doi-asserted-by":"crossref","first-page":"619","DOI":"10.7326\/0003-4819-152-9-201005040-00022","article-title":"Respiratory failure caused by 2009 novel influenza A\/H1N1 in a hematopoietic stem-cell transplant recipient: detection of extrapulmonary H1N1 RNA and use of intravenous peramivir","volume":"152","author":"Campbell","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2015.12.003_bib23","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/bmt.2011.57","article-title":"Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic hematopoietic SCT","volume":"47","author":"Mohty","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.12.003_bib24","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2169\/internalmedicine.42.1127","article-title":"Influenza-induced rhabdomyolysis after autologous peripheral blood stem cell transplantation for malignant lymphoma","volume":"42","author":"Nozoe","year":"2003","journal-title":"Intern Med"},{"key":"10.1016\/j.bbmt.2015.12.003_bib25","first-page":"1","article-title":"Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients","volume":"11","author":"Engelhard","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.12.003_bib26","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.bmt.1703239","article-title":"Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients","volume":"28","author":"Gandhi","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.12.003_bib27","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2141.2004.05204.x","article-title":"Measuring T cell immunity to influenza vaccination in children after haemopoietic stem cell transplantation","volume":"127","author":"Haining","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2015.12.003_bib28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/sj.bmt.1705064","article-title":"Cell-mediated immune responses to influenza vaccination in healthy volunteers and allogeneic stem cell transplant recipients","volume":"36","author":"Avetisyan","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.12.003_bib29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/TP.0b013e3181772a75","article-title":"Evaluation of immune responses to seasonal influenza vaccination in healthy volunteers and in patients after stem cell transplantation","volume":"86","author":"Avetisyan","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2015.12.003_bib30","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1016\/j.vaccine.2009.02.053","article-title":"Intradermal influenza vaccination in immunocompromized patients is immunogenic and feasible","volume":"27","author":"Gelinck","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.bbmt.2015.12.003_bib31","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00277-009-0897-1","article-title":"Serological response to influenza vaccine after hematopoietic stem cell transplantation","volume":"89","author":"Yalcin","year":"2010","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2015.12.003_bib32","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.bbmt.2010.04.015","article-title":"CD154 expression is associated with neutralizing antibody titer levels postinfluenza vaccination in stem cell transplant patients and healthy adults","volume":"17","author":"Seidel","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.12.003_bib33","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.vaccine.2010.12.113","article-title":"The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A\/California\/7\/2009 (H1N1)v-like virus vaccine during the 2009 pandemic","volume":"29","author":"Engelhard","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.bbmt.2015.12.003_bib34","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.bbmt.2010.10.002","article-title":"Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients","volume":"17","author":"Issa","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.12.003_bib35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbmt.2012.08.015","article-title":"A\u00a0randomized trial of one versus two doses of influenza vaccine after allogeneic transplantation","volume":"19","author":"Karras","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.12.003_bib36","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1086\/313663","article-title":"Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients","volume":"30","author":"Pauksen","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2015.12.003_bib37","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3324\/haematol.2011.040386","article-title":"Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A\/09\/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients","volume":"96","author":"Mohty","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2015.12.003_bib38","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.bbmt.2011.02.004","article-title":"Enhanced immune response after a second dose of an AS03-adjuvanted H1N1 influenza A vaccine in patients after hematopoietic stem cell transplantation","volume":"17","author":"Gueller","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.12.003_bib39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s15010-011-0206-5","article-title":"Vaccination against pandemic H1N1 (2009) in patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis","volume":"40","author":"Roll","year":"2012","journal-title":"Infection"},{"key":"10.1016\/j.bbmt.2015.12.003_bib40","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1086\/599790","article-title":"Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older","volume":"200","author":"Falsey","year":"2009","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.bbmt.2015.12.003_bib41","first-page":"485","article-title":"Licensure of a high-dose inactivated influenza vaccine for persons aged >or=65 years (Fluzone High-Dose) and guidance for use - United States, 2010","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.bbmt.2015.12.003_bib42","doi-asserted-by":"crossref","first-page":"7656","DOI":"10.1016\/j.vaccine.2007.08.042","article-title":"Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects","volume":"25","author":"Couch","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.bbmt.2015.12.003_bib43","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archinte.166.10.1121","article-title":"Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons","volume":"166","author":"Keitel","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bbmt.2015.12.003_bib44","series-title":"Concepts and procedures for laboratory-based influenza surveillance","year":"1982"},{"key":"10.1016\/j.bbmt.2015.12.003_bib45","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1128\/cdli.3.5.507-510.1996","article-title":"Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly","volume":"3","author":"Keitel","year":"1996","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.bbmt.2015.12.003_bib46","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/petr.12419","article-title":"Randomized, double-blind comparison of standard-dose vs. high-dose trivalent inactivated influenza vaccine in pediatric solid organ transplant patients","volume":"19","author":"GiaQuinta","year":"2015","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.bbmt.2015.12.003_bib47","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/pbc.24863","article-title":"Safety of high dose trivalent inactivated influenza vaccine in pediatric patients with acute lymphoblastic leukemia","volume":"61","author":"McManus","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2015.12.003_bib48","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa1315727","article-title":"Efficacy of high-dose versus standard-dose influenza vaccine in older adults","volume":"371","author":"DiazGranados","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2015.12.003_bib49","first-page":"1","article-title":"WHO Expert Committee on biological standardization","volume":"963","year":"2011","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.bbmt.2015.12.003_bib50","doi-asserted-by":"crossref","first-page":"10905","DOI":"10.1128\/JVI.00700-11","article-title":"A\u00a0broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin","volume":"85","author":"Krause","year":"2011","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.bbmt.2015.12.003_bib51","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/infdis\/jit813","article-title":"Survey of human antibody responses to influenza virus matrix protein 2 by use of a sensitive flow cytometric method","volume":"209","author":"Epstein","year":"2014","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.bbmt.2015.12.003_bib52","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1128\/JVI.01503-10","article-title":"Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses","volume":"85","author":"Pena","year":"2011","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.bbmt.2015.12.003_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciq015","article-title":"Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1","volume":"52","author":"Berthoud","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2015.12.003_bib54","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s11095-013-1224-z","article-title":"Comparison of PLA microparticles and alum as adjuvants for H5N1 influenza split vaccine: adjuvanticity evaluation and preliminary action mode analysis","volume":"31","author":"Zhang","year":"2014","journal-title":"Pharm Res"},{"key":"10.1016\/j.bbmt.2015.12.003_bib55","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/infdis\/jir769","article-title":"GLA-SE, a synthetic toll-like receptor 4 agonist, enhances T-cell responses to influenza vaccine in older adults","volume":"205","author":"Behzad","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.bbmt.2015.12.003_bib56","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879115018649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879115018649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:54:57Z","timestamp":1761058497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879115018649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1083879115018649"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2015.12.003","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenza Vaccine in Adult Hematopoietic Stem Cell Transplantation Patients","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2015.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}